TMEM14B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.865600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.030200E-01
Normal-vs-Stage2
6.918600E-01
Normal-vs-Stage3
4.950000E-01
Normal-vs-Stage4
4.400400E-01
Stage1-vs-Stage2
9.788600E-01
Stage1-vs-Stage3
6.356200E-01
Stage1-vs-Stage4
4.925000E-01
Stage2-vs-Stage3
4.997000E-01
Stage2-vs-Stage4
3.604800E-01
Stage3-vs-Stage4
2.332800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.878600E-01
Normal-vs-AfricanAmerican
8.026600E-01
Normal-vs-Asian
8.228600E-01
Caucasian-vs-AfricanAmerican
7.419000E-01
Caucasian-vs-Asian
6.299400E-01
AfricanAmerican-vs-Asian
9.670600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.487800E-01
Normal-vs-Female
5.270000E-01
Male-vs-Female
1.004230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.481500E-02
Normal-vs-Age(41-60Yrs)
9.563800E-01
Normal-vs-Age(61-80Yrs)
6.049600E-01
Normal-vs-Age(81-100Yrs)
4.613600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.093610E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.989400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.388400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.012400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.771450E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.903570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.846600E-01
Normal-vs-Daily Drinker
4.106400E-01
Normal-vs-Weekly Drinker
6.505800E-01
Normal-vs-Occasional Drinker
2.883400E-01
Normal-vs-Social Drinker
6.064600E-01
Non Drinker-vs-Daily Drinker
2.955600E-01
Non Drinker-vs-Weekly Drinker
9.831000E-01
Non Drinker-vs-Occasional Drinker
2.174000E-01
Non Drinker-vs-Social Drinker
7.063800E-01
Daily Drinker-vs-Weekly Drinker
3.046400E-01
Daily Drinker-vs-Occasional Drinker
2.434400E-02
Daily Drinker-vs-Social Drinker
5.222800E-01
Weekly Drinker-vs-Occasional Drinker
2.613400E-01
Weekly Drinker-vs-Social Drinker
6.788600E-01
Occasional Drinker-vs-Social Drinker
1.179230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.181200E-01
Normal-vs-Grade 2
1.547150E-01
Normal-vs-Grade 3
2.002400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.563800E-01
Grade 1-vs-Grade 3
7.999000E-01
Grade 1-vs-Grade 4
3.181200E-01
Grade 2-vs-Grade 3
4.275400E-01
Grade 2-vs-Grade 4
1.547150E-01
Grade 3-vs-Grade 4
2.002400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.035240E-01
Normal-vs-NonDiabetic
8.308600E-01
Diabetic-vs-NonDiabetic
1.510010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.820800E-01
Normal-vs-NoPancreatitis
6.636400E-01
Pancreatitis-vs-NoPancreatitis
1.798840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.845800E-01
Normal-vs-N1
7.754400E-01
N0-vs-N1
8.715400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.890400E-01
Normal-vs-TP53-NonMutant
9.498800E-01
TP53-Mutant-vs-TP53-NonMutant
1.056040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
